Diana Papaioannou
BChD, MSc
School of Medicine and Population Health
Senior Research Fellow/Portfolio Lead
CTRU Deputy Director
+44 114 222 0766
Full contact details
School of Medicine and Population Health
Barber House
Sheffield
S10 2HQ
- Profile
-
Diana Papaioannou is an Assistant Director of the Clinical Trials Research Unit (CTRU) and a Senior Research Fellow with expertise in trial conduct and methodology and CTIMP trials (Clinical Trials of Investigational Medicinal Products).
Diana has extensive experience in designing and implementing large multi-centre trials, particularly CTIMP trials. Since 2014, she has been co-applicant on 8 NIHR funded trials. Diana also held a Clinical Trials Unit (CTU) Efficient Trials award to develop recommendations for recording harms in behaviour change interventions. Diana was the Quality Assurance Lead for Sheffield CTRU between 2014 to 2024.
Diana is CTRU lead, providing senior CTRU oversight, for the following studies: EXPERTS-ALS (NIHR158515), MISSION-EB (NHSE/NIHR EME: 127963), PRAISE (NIHR153170) and MAP (NIHR167171).
Diana previously provided CTRU senior oversight and a co-applicant on the MAGIC trial (NIHR HTA: 16/80/08) and STAR-MS trials (NIHR EME: 16/126/26). I provided CTIMP expertise to the ASTIClite trial (NIHR EME: 15/178/09).
In 2019, Diana became Assistant Director at CTRU, responsible for the CTRU management with the CTRU Director and the CTRU management group and coordinating the CTRU
Diana joined the CTRU in May 2011 as the Trial Co-ordinator for a multi-centre randomised controlled trial, REPOSE (The Relative Effectiveness of Pumps over MDI and Structured Education for Type-1 diabetes).
Prior to joining CTRU, she worked with the ScHARR Technology Assessment Group from July 2006, as an Information Specialist and Systematic Reviewer undertaking health technology assessments for the National Institute for Health and Clinical Excellence (NICE) and the NIHR Evaluation, Trials and Studies Coordinating Centre (NETSCC).
- Research interests
-
- Clinical trial design
- Clinical trials of Investigational Medicinal Products
- Adverse event recording in behavioural trials
- Systematic reviews
- Publications
-
Show: Featured publications All publications
Featured publications
Books
Journal articles
- Barriers and enablers to recruiting participants within paediatric perioperative and anaesthetic settings: lessons learned from a trial of melatonin versus midazolam in the premedication of anxious children (the MAGIC trial). BJA Open, 13. View this article in WRRO
- Acceptability of midazolam and melatonin as premedications for anxious children undergoing general anaesthesia: a qualitative interview study with children, caregivers and health professionals participating in the MAGIC trial. Trials, 25(1). View this article in WRRO
- Recommendations on recording harms in randomised controlled trials of behaviour change interventions. BMJ, 387. View this article in WRRO
- Recording harms in randomised controlled trials of behaviour change interventions: a qualitative study of UK clinical trials units and NIHR trial investigators. Trials, 25. View this article in WRRO
- Systematic searching and selection of health state utility values from the literature. Value in Health, 16(4), 686-695.
- How to measure quality of life for cost-effectiveness analyses of personality disorders: a systematic review.. J Pers Disord, 27(3), 383-401.
- Rituximab for the first-line treatment of stage III-IV follicular lymphoma (review of Technology Appraisal No. 110): a systematic review and economic evaluation.. Health Technol Assess, 16(37), 1-iv.
- The National Institute for Health and Clinical Excellence Single Technology Appraisal process: lessons from the first 4 years.. Value Health, 14(8), 1158-1165.
- How valid and responsive are generic health status measures, such as EQ-5D and SF-36, in schizophrenia? A systematic review.. Value Health, 14(6), 907-920.
- Trabectedin for the treatment of relapsed ovarian cancer.. Health Technol Assess, 15 Suppl 1, 69-75.
- The clinical effectiveness and safety of prophylactic retinal interventions to reduce the risk of retinal detachment and subsequent vision loss in adults and children with Stickler syndrome: a systematic review.. Health Technol Assess, 15(16), iii-62.
- Antioxidants in the chemoprevention of colorectal cancer and colorectal adenomas in the general population: a systematic review and meta-analysis.. Colorectal Dis, 13(10), 1085-1099.
- Chemoprevention of colorectal cancer: systematic review and economic evaluation.. Health Technol Assess, 14(32), 1-206.
- Literature searching for social science systematic reviews: consideration of a range of search techniques. HEALTH INFO LIBR J, 27(2), 114-122.
- The role of the information specialist in supporting knowledge transfer: a public health information case study.. Health Info Libr J, 26(2), 118-125.
Book chapters
- Identifying and reviewing health state utility values for populating decision models In Shemilt I, Mugford M, Vale L, Donaldson C & Marsh K (Ed.), Evidence-Based Decisions and Economics: Health Care, Social Welfare, Education and Criminal Justice (pp. 93-105). Wiley-Blackwell
Conference proceedings
- THE VALIDITY OF THE EQ-5D, SF-6D, SF-36 AND SF-12 IN MENTAL HEALTH CONDITIONS: A SYSTEMATIC REVIEW. VALUE IN HEALTH, Vol. 14(7) (pp A239-A239)
All publications
There has been a problem showing this information. Please try again later.
- Barriers and enablers to recruiting participants within paediatric perioperative and anaesthetic settings: lessons learned from a trial of melatonin versus midazolam in the premedication of anxious children (the MAGIC trial). BJA Open, 13. View this article in WRRO
- Research group
-
CTRU, DTS
- Grants
-
Metformin and Psychosis Weight Prevention Trial (MAP Trial). NIHR HTA.
Coapplicant. £3million
EXPErimental medicine Route To Success in Amyotrophic Lateral Sclerosis
(EXPERTS-ALS) NIHR EME and NIHR BRC. Coapplicant. £4,796,266.62. Start date:
1 Sep 2023.
Recording Harms in Behavioural change Intervention Trials (RHABIT) Project. NIHR CTU support funding for Efficient trials. Principal Investigator. £79,015
MissionEB trial: Double blinded placebo control study of Mesenchymal Intravenous
Stromal cell Infusions in children with recessive dystrophic Epidermolysis Bullosa.
Coapplicant. £2,539,714. Start date Aug 2020
STAR-MS trial: Autologous Stem Cell Transplantation versus Alemtuzumab in
Relapsing Remitting MS. Coapplicant. £2,350,322. Start date Jan 2019
The MAGIC trial: Melatonin for Anxiety prior to General Anaesthesia. HTA 16/80/08,
Coapplicant.£1.65million. Dec 2017 to September 2024.
Autologous Stem Cell Transplantation In refractory Crohns disease - Low Intensity
Therapy Evaluation (ASTIC-LITE). Sep 2017 to 2021
SCRATCH trial (Induced Endometrial Trauma in IVF). HTA 14/08/05, Coapplicant.
£1.25million. Dec 2015 to Sep 2020
- Teaching interests
-
I am interested in supervising research students in areas such as RCT methodology and evaluation of health technologies.